e-learning
resources
Vienna 2003
Sunday 28.09.2003
Advances in our understanding of corticosteroids in the treatment of asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Asthma treatment based on sputum cell counts or usual clinical outcomes: the LOMA study
M. M. M. Pizzichini, L. Jayaram, P. Hussack, L. P. Boulet, C. Lemiere, A. Efthimiadis, A. Cartier, E. Pizzichini, F. E. Hargreave (Hamilton, Quebec, Montreal, Canada; Florianopolis, Brazil)
Source:
Annual Congress 2003 - Advances in our understanding of corticosteroids in the treatment of asthma
Session:
Advances in our understanding of corticosteroids in the treatment of asthma
Session type:
Poster Discussion
Number:
343
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. M. M. Pizzichini, L. Jayaram, P. Hussack, L. P. Boulet, C. Lemiere, A. Efthimiadis, A. Cartier, E. Pizzichini, F. E. Hargreave (Hamilton, Quebec, Montreal, Canada; Florianopolis, Brazil). Asthma treatment based on sputum cell counts or usual clinical outcomes: the LOMA study. Eur Respir J 2003; 22: Suppl. 45, 343
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Usefulness of induced sputum eosinophil count to assess severity and treatment outcome in asthma patients
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations
Source: Eur Respir J 2006; 27: 483-494
Year: 2006
Missing sputum samples are common in asthma intervention studies and successful collection at follow-up is related to improvement in clinical outcomes
Source: ERJ Open Res, 8 (1) 00612-2021; 10.1183/23120541.00612-2021
Year: 2022
A new observer independent method to assess therapy response in children with severe asthma based on daily lung function
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013
Clinical-functional and inflammatory evolution after one year of tracking in patients with asthma according to induced sputum cellularity
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
Asthma control and sputum eosinophils: A longitudinal study in daily practice
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
COPD therapy based on clinical phenotypes: Baseline data from the Czech multicentre research database of COPD
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Induced sputum: standardisation of methods and cell counts in a multi-centre trial
Source: Eur Respir J 2003; 22: Suppl. 45, 412s
Year: 2003
The ARIETTA study: baseline demographics in a real-world setting in patients with severe asthma
Source: International Congress 2017 – Bronchial asthma management
Year: 2017
How different operators performing sputum eosinophil differential cell counts may affect clinical decisions for severe asthma patients.
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020
The control of asthma in real life: Baseline evaluation of a long-term study
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016
Follow-up of patients with uncontrolled asthma: clinical features of asthma patients according to the level of control achieved (the COAS study)
Source: Eur Respir J , 49 (3) 1501885; DOI: 10.1183/13993003.01885-2015
Year: 2017
The Spanish national clinical audit on COPD exacerbations. results of a pilot study: spirometry outcomes
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008
A national database study of the effectiveness of switching real-life asthma patients to fostair
Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis
Year: 2015
Impact of adherence to fluticasone propionate/salmeterol combination (FSC) therapy on the outcomes of patients with asthma: A population based study
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013
Study of the adherence to treatment in asthma according to clinical, psychological and educational parameters
Source: Eur Respir J 2001; 18: Suppl. 33, 44s
Year: 2001
One year dynamics of life quality depending on the adherence to therapy in patients with bronchial asthma
Source: Annual Congress 2013 –Asthma at the bedside
Year: 2013
Based on what parameters of clinical remission should inhaled corticosteroids be stopped in children with asthma?
Source: Annual Congress 2013 –The best of paediatric asthma and allergy
Year: 2013
Patients’ adherence to chronic treatment in lung diseases: Preliminary data from a randomized controlled trial
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016
Examination of variations in responder rates in COPD clinical trial outcomes
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept